- Filed
- Nov 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 29, 2025 | 2.73M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 2.32M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2023 | $4K |
| Capex | FY 2024 · Dec 31, 2023 | $11K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$4.19M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $205K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $4.69M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $4.79M |
| Current Assets | FY 2024 · Dec 31, 2023 | $1.76M |
| Total Assets | FY 2024 · Dec 31, 2023 | $4.72M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$0.95 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.95 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $6.01M |
| Net Income | FY 2024 · Dec 31, 2023 | −$2.2M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$6.41M |
| Gross Profit | FY 2024 · Dec 31, 2023 | −$387K |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $2.73M |
| Revenue | FY 2024 · Dec 31, 2023 | $2.35M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | −$724K |